Oncogenic Heterogeneous Nuclear Ribonucleoprotein D-like Modulates the Growth and Imatinib Response of Human Chronic Myeloid Leukemia CD34 Cells Via Pre-B-cell Leukemia Homeobox 1

Overview

Journal Oncogene

Specialties Molecular Biology
Oncology

Date 2019 Sep 7

PMID 31488872

Citations 6

Authors

Dehuan Ji

Pengshan Zhang

Wenjuan Ma

Yiwen Fei

Wen Xue

Yu Wang

Xiuyan Zhang

Haixia Zhou

Yun Zhao

Affiliations

Soon will be listed here.

Abstract

Chronic myeloid leukemia (CML) originates from normal hematopoietic stem cells acquiring BCR-ABL fusion gene, specific BCR-ABL inhibitors (e.g., imatinib mesylate, IM) have greatly improved patient management. However, some patients are still suffering from relapse and drug resistance, which urges better understanding of the growth/survival mechanisms of CML stem/progenitor cells. In the present study, the role and its underlying mechanism of heterogeneous nuclear ribonucleoprotein D-like (HNRPDL) in CML cells were investigated. Firstly, overexpression of HNRPDL promoted the growth of murine BaF3 cells in vitro and induced leukemia in vivo, which was enhanced by co-expression of BCR-ABL. Conversely, HNRPDL silencing inhibited colony-forming cell (CFC) production of CML CD34 cells and attenuated BCR-ABL induced leukemia. In addition, HNRPDL modulated imatinib response of K562 cells and HNRPDL silencing sensitized CML CD34 cells to imatinib treatment. Mechanistically, we found the stability of pre-B-cell leukemia homeobox 1 (PBX1) mRNA was sustained by HNRPDL through its binding to a specific motif (ACUAGC) in 3'-untranslated region (3'-UTR) of PBX1. The expression of PBX1 was significantly higher in CML CD34 cells than that in control cells and PBX silencing inhibited the growth of CML cells and sensitized them to imatinib treatment. In contrast, overexpression of PBX1 elevated the CFC production of normal hematopoietic CD34 cells and "rescued" HNRPDL silencing induced growth inhibition and imatinib sensitization. Taken together, our data have demonstrated that HNRPDL transforms hematopoietic cells and a novel HNRPDL/PBX1 axis plays an important role in human CML CD34 cells.

Citing Articles

Insights into Structure and Function of Growth Arrest Specific 2 (GAS2).

Ma W, Lin J, Ma R, Bai Y, Wu D, Zhang X J Cancer. 2025; 16(1):146-156.

PMID: 39744572 PMC: 11660135. DOI: 10.7150/jca.102893.

miR-181a plays the tumor-suppressor role in chronic myeloid leukemia CD34 cells partially via SERPINE1.

Zhang X, Ma W, Xue W, Wang Y, Chen P, Li Q Cell Mol Life Sci. 2023; 81(1):10.

PMID: 38103082 PMC: 10725356. DOI: 10.1007/s00018-023-05036-8.

A conserved ZFX/WNT3 axis modulates the growth and imatinib response of chronic myeloid leukemia stem/progenitor cells.

Zhang X, Wang Y, Lu J, Xiao L, Chen H, Li Q Cell Mol Biol Lett. 2023; 28(1):83.

PMID: 37864206 PMC: 10589942. DOI: 10.1186/s11658-023-00496-z.

The splicing factor RBM17 drives leukemic stem cell maintenance by evading nonsense-mediated decay of pro-leukemic factors.

Liu L, Vujovic A, Deshpande N, Sathe S, Anande G, Chen H Nat Commun. 2022; 13(1):3833.

PMID: 35781533 PMC: 9250932. DOI: 10.1038/s41467-022-31155-0.

HNRNPH1 Is a Novel Regulator Of Cellular Proliferation and Disease Progression in Chronic Myeloid Leukemia.

Liu M, Yang L, Liu X, Nie Z, Zhang X, Lu Y Front Oncol. 2021; 11:682859.

PMID: 34295818 PMC: 8290130. DOI: 10.3389/fonc.2021.682859.

References

Dreyfuss G, Matunis M, Pinol-Roma S, Burd C . hnRNP proteins and the biogenesis of mRNA. Annu Rev Biochem. 1993; 62:289-321. DOI: 10.1146/annurev.bi.62.070193.001445. View

Geuens T, Bouhy D, Timmerman V . The hnRNP family: insights into their role in health and disease. Hum Genet. 2016; 135(8):851-67. PMC: 4947485. DOI: 10.1007/s00439-016-1683-5. View

Wang Y, Xiao X, Zhang J, Choudhury R, Robertson A, Li K . A complex network of factors with overlapping affinities represses splicing through intronic elements. Nat Struct Mol Biol. 2012; 20(1):36-45. PMC: 3537874. DOI: 10.1038/nsmb.2459. View

Doi A, Shiosaka T, Takaoka Y, Yanagisawa K, Fujita S . Molecular cloning of the cDNA encoding A + U-rich element RNA binding factor. Biochim Biophys Acta. 1998; 1396(1):51-6. DOI: 10.1016/s0167-4781(97)00223-6. View

Tsuchiya N, Kamei D, Takano A, Matsui T, Yamada M . Cloning and characterization of a cDNA encoding a novel heterogeneous nuclear ribonucleoprotein-like protein and its expression in myeloid leukemia cells. J Biochem. 1998; 123(3):499-507. DOI: 10.1093/oxfordjournals.jbchem.a021964. View

Kawamura H, Tomozoe Y, Akagi T, Kamei D, Ochiai M, Yamada M . Identification of the nucleocytoplasmic shuttling sequence of heterogeneous nuclear ribonucleoprotein D-like protein JKTBP and its interaction with mRNA. J Biol Chem. 2001; 277(4):2732-9. DOI: 10.1074/jbc.M108477200. View

Imasaki T, Shimizu T, Hashimoto H, Hidaka Y, Kose S, Imamoto N . Structural basis for substrate recognition and dissociation by human transportin 1. Mol Cell. 2007; 28(1):57-67. DOI: 10.1016/j.molcel.2007.08.006. View

Kamei D, Yamada M . Interactions of heterogeneous nuclear ribonucleoprotein D-like protein JKTBP and its domains with high-affinity binding sites. Gene. 2002; 298(1):49-57. DOI: 10.1016/s0378-1119(02)00926-5. View

Bandiera A, Tell G, Marsich E, Scaloni A, Pocsfalvi G, Akindahunsi A . Cytosine-block telomeric type DNA-binding activity of hnRNP proteins from human cell lines. Arch Biochem Biophys. 2002; 409(2):305-14. DOI: 10.1016/s0003-9861(02)00413-7. View

10.

Reboll M, Oumard A, Gazdag A, Renger I, Ritter B, Schwarzer M . NRF IRES activity is mediated by RNA binding protein JKTBP1 and a 14-nt RNA element. RNA. 2007; 13(8):1328-40. PMC: 1924892. DOI: 10.1261/rna.545407. View

11.

Omnus D, Mehrtens S, Ritter B, Resch K, Yamada M, Frank R . JKTBP1 is involved in stabilization and IRES-dependent translation of NRF mRNAs by binding to 5' and 3' untranslated regions. J Mol Biol. 2011; 407(4):492-504. DOI: 10.1016/j.jmb.2011.01.050. View

12.

Boopathi E, Lenka N, Prabu S, Fang J, Wilkinson F, Atchison M . Regulation of murine cytochrome c oxidase Vb gene expression during myogenesis: YY-1 and heterogeneous nuclear ribonucleoprotein D-like protein (JKTBP1) reciprocally regulate transcription activity by physical interaction with the BERF-1/ZBP-89.... J Biol Chem. 2004; 279(34):35242-54. DOI: 10.1074/jbc.M403160200. View

13.

Vieira N, Naslavsky M, Licinio L, Kok F, Schlesinger D, Vainzof M . A defect in the RNA-processing protein HNRPDL causes limb-girdle muscular dystrophy 1G (LGMD1G). Hum Mol Genet. 2014; 23(15):4103-10. DOI: 10.1093/hmg/ddu127. View

14.

Bonnet C, Andrieux J, Beri-Dexheimer M, Leheup B, Boute O, Manouvrier S . Microdeletion at chromosome 4q21 defines a new emerging syndrome with marked growth restriction, mental retardation and absent or severely delayed speech. J Med Genet. 2010; 47(6):377-84. DOI: 10.1136/jmg.2009.071902. View

15.

Hu X, Chen X, Wu B, Soler I, Chen S, Shen Y . Further defining the critical genes for the 4q21 microdeletion disorder. Am J Med Genet A. 2016; 173(1):120-125. DOI: 10.1002/ajmg.a.37965. View

16.

Kurokawa Y, Matoba R, Takemasa I, Nakamori S, Tsujie M, Nagano H . Molecular features of non-B, non-C hepatocellular carcinoma: a PCR-array gene expression profiling study. J Hepatol. 2003; 39(6):1004-12. DOI: 10.1016/s0168-8278(03)00473-2. View

17.

Wu Y, Li H, Lv X, Wei Q, Li X, Liu X . Overexpression of JKTBP1 induces androgen-independent LNCaP cell proliferation through activation of epidermal growth factor-receptor (EGF-R). Cell Biochem Funct. 2008; 26(4):467-77. DOI: 10.1002/cbf.1468. View

18.

Zhang P, Ji D, Hu X, Ni H, Ma W, Zhang X . Oncogenic heterogeneous nuclear ribonucleoprotein D-like promotes the growth of human colon cancer SW620 cells via its regulation of cell-cycle. Acta Biochim Biophys Sin (Shanghai). 2018; 50(9):880-887. DOI: 10.1093/abbs/gmy085. View

19.

Zhou H, Ge Y, Sun L, Ma W, Wu J, Zhang X . Growth arrest specific 2 is up-regulated in chronic myeloid leukemia cells and required for their growth. PLoS One. 2014; 9(1):e86195. PMC: 3897655. DOI: 10.1371/journal.pone.0086195. View

20.

Al-Ghoul M, Bruck T, Lauer-Fields J, Asirvatham V, Zapata C, Kerr R . Comparative proteomic analysis of matched primary and metastatic melanoma cell lines. J Proteome Res. 2008; 7(9):4107-18. DOI: 10.1021/pr800174k. View